High-risk HPV clearance and CIN 3 treated with MAL-PDT: A case report

•CIN 3 and high-risk HPV virus were eliminated 120 days after two PDT procedures.•Colposcopy, cytology, and PCR-HPV RNA were negative on the 6 months follow-up.•Topical MAL-PDT illuminating ecto and endocervix simultaneously could be a promising strategy to treat high-grade CIN. High-grade cervical...

Full description

Saved in:
Bibliographic Details
Published inPhotodiagnosis and photodynamic therapy Vol. 31; p. 101937
Main Authors de Castro, Cynthia Aparecida, Lombardi, Welington, Stringasci, Mirian Denise, Bagnato, Vanderlei Salvador, Inada, Natalia Mayumi
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•CIN 3 and high-risk HPV virus were eliminated 120 days after two PDT procedures.•Colposcopy, cytology, and PCR-HPV RNA were negative on the 6 months follow-up.•Topical MAL-PDT illuminating ecto and endocervix simultaneously could be a promising strategy to treat high-grade CIN. High-grade cervical intraepithelial neoplasia (CIN) is the precursor to cervical cancer. HPV (human papillomavirus) infection is strongly related with this disease. The CIN treatment is generally excision of the transformation zone (ETZ). Photodynamic therapy (PDT) has also shown to be a promising treatment. We are reporting a case of a 33-years-old patient with high-grade CIN 3 treated with topical MAL (methyl aminolevulinate) PDT. Was applied 2.5 g of 20 % (w/w) MAL cream overnight and the cervix was illuminated twice, with three weeks apart, using a probe with LEDs simultaneously with a cylindrical laser fiber emitting both at 630 nm, with a fluency of 150 J/cm2. CIN 3 and the presence of high-risk HPV virus was eliminated 120 days after the second procedure. There was no recurrence at 6 months follow-up. This case report using MAL-PDT and a different light arrangement with LEDs and laser fiber associated both cured the patient with CIN 3 and eliminated low and high-risk HPV in just two PDT sessions.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1572-1000
1873-1597
DOI:10.1016/j.pdpdt.2020.101937